openPR Logo
Press release

The Future Of Generic Drugs And Strategies For Commercial Success

10-24-2016 11:10 AM CET | Health & Medicine

Press release from: Generic Drugs

GBI Research’s latest report “The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the global generic drugs market, and the evolving business strategies being adopted and leveraged by generic drug companies around the world. GBI Research conducted an extensive and targeted industry survey of experts from top global generic drug companies, to gather opinions on the trends and future commercial prospects of the generic drugs market. The findings from the survey and results from extensive data analysis and secondary research efforts have been triangulated with GBI’s own analytical views to provide an objective assessment that is comprehensive in outlook.

The generic drugs market has seen rapid expansion for more than 30 years, and consistently achieves higher annual growth rates than the overall pharmaceutical market. The increase in generic drug activity can be primarily attributed to the promise of significant revenues from blockbuster drugs nearing patent expiry. In the US – the largest generic drugs market by revenue – the number of generic drug approvals hit a record high in 2015, due to a new program that aimed to speed up approvals. There has also recently been a surge in the number of industry-transforming mergers and acquisitions, with companies looking to consolidate their position in this highly lucrative market.

The results of GBI’s latest industry survey provide insightful analyses from different expert panels, including R&D and commercial, and highlight trends observed in key geographical markets. The survey examined key commercial issues and recent developments in the generic drugs market, such as the reasons behind the surge in mergers and acquisitions, and the likely effects on market dynamics. It covered important factors currently driving or restraining the market, prospects for key therapy areas expected to exhibit significant levels of genericization in the coming years, and the most promising emerging markets for generic companies in terms of revenue potential. Additionally, the survey examined common business strategies and regulations being leveraged by global generic drug companies for market expansion.

The report covers key small molecule drugs whose patents will expire in the coming years, providing an in-depth assessment of potential generic competition, expected launch dates and the overall impact on global branded revenues to 2021. The top global generic drug companies by revenue are also examined, including financial performance and recent activity within the market.

This new report adds to our unique portfolio of trusted industry analyses, which enable our clients to assess the most promising commercial areas in the market and identify key business opportunities.

Scope

What is the current value of the generic drugs market, and how will market dynamics change in the coming years?
Will the US continue to dominate the market?
Which therapy areas will witness the highest level of genericization in the next five years?
Drivers and restraints in the generics industry:

What are the most important factors promoting generic drug usage at a global level?
What are the most important factors hindering or delaying generic drug approvals?
Will governments worldwide continue their efforts to promote generic drug usage?
How will global demographic trends impact demand for generic drugs?
Which emerging economies are the most promising for generic drugs companies?
Are generic drugs still negatively perceived?
How are pricing pressures and rising costs affecting generic drug manufacturers?
Generic drugs pipeline for top small molecule drugs in the market:
What will be the revenue impact for key small molecule drugs whose patents expire in the near future?
What are the key patent expiry dates for these small molecules and what level of generic competition should they expect?
Strategies for commercial success:
What are the most popular strategies or regulations being adopted and leveraged by generic drug manufacturers?
What governmental policies are significantly influencing generic drug usage?
What will be the impact of compulsory licenses in emerging markets?
Mergers and acquisitions in the global generic drugs market:
What are the most important factors contributing to the surge in M&A activity in the generic drugs market?
How will market dynamics be affected by continued consolidation in the generic drugs market?
What have been the most important transactions in the generic drugs industry in recent years?
Top global generic drugs companies:
How have top generic drugs companies performed in recent years?
What are the prospects for top generic drugs companies?

Request sample copy of report at http://www.marketresearchreports.biz/sample/sample/848086

Reasons to buy

This report will allow you to

Gain insightful analyses and understanding of market dynamics: This report comprehensively describes and assesses the most important factors driving and restraining the generic drugs market. It assesses pertinent commercial and regulatory aspects of the industry by combining survey results with proprietary in-house expertise and extensive secondary research efforts.
Assess the generic drugs pipeline for top small molecule drugs in the market: Our study provides prospects for these drugs beyond their patent expiries, including potential generic competition, expected launch dates and revenue forecasts to 2021.
Evaluate the strategies used by companies to promote generic drug usage: This report provides insights regarding the various commercial strategies being adopted and leveraged by generic drug companies to promote their therapies.
Understand government policies and strategies to promote generic drug usage: This report assesses current strategies and regulations implemented by governments in key geographic markets to promote generic drug usage.
Gain insight on mergers and acquisitions in the global generic drugs market: This report describes industry-transforming mergers and acquisitions that have occurred in recent years, the reasons behind the recent surge in these types of transactions, and their likely impact on market dynamics.

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Future Of Generic Drugs And Strategies For Commercial Success here

News-ID: 375633 • Views:

More Releases from Generic Drugs

Global Generic Drugs Market Report 2019 Companies included Sanofi, Aurobindo, Lupin, Dr. Reddy's, Apotex, Cipla and Others
Global Generic Drugs Market Report 2019 Companies included Sanofi, Aurobindo, Lu …
Market Reports Company has recently published 7th edition of Generic Drugs Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026. For inquiry or free sample pages email us at: sales@marketreportscompany.com The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Generic Drugs market was valued at USD xx
Generic Wellness Offers Special Discount on Generic Xenical for Fat Reduction !
Generic Wellness Offers Special Discount on Generic Xenical for Fat Reduction !
This week a special offer is introduced by Generic Wellness for weight loss treatment with an oral drug called generic Xenical. The drug is an excellent weight loss treatment for all men and women above the age of 12. People who have taken this drug for weight loss have actually experienced the benefits like reduction of unwanted fat in the body. This is possible with generic Xenical because of the
New Study Reveals Future of Generic Drugs and Strategies for Commercial Success | Researchmoz
New Study Reveals Future of Generic Drugs and Strategies for Commercial Success …
Researchmoz added Most up-to-date research on "The Future of Generic Drugs and Strategies for Commercial Success" to its huge collection of research reports. Latest report “The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the global generic drugs market, and the evolving business strategies being adopted and leveraged by generic drug companies around the world. GBI Research conducted an extensive and targeted industry survey of experts from
Global Generic Drugs Market To Be Driven By Consistent Government Support
The report studies the global market for generic drugs and presents a thorough analysis of the factors expected to play a key role in the development of the market in the coming years. The comprehensive coverage of the generic drugs market and reliable projections provided in the report make it a must-have accessory for established as well as prospective players in the generic drugs market. The report is titled ‘The

All 5 Releases


More Releases for GBI

Cancer vaccines market will soar to $7.5 billion by 2022, says GBI Research
The cancer vaccines market is set to almost triple from $2.5 billion in 2015 to $7.5 billion by 2022, representing a strong compound annual growth rate of 16.93%. Adam Bradbury, Associate Analyst for GBI Research, explains: “The cancer vaccines space will see such impressive growth over next decade for a number of reasons. There is a fairly large cancer vaccine pipeline, with over 1,200 products being developed, accounting for almost 17%
GBI: Top Ten Clean Technology Trends in 2011 on reports-research.com
GBI Research's new report, Top Ten Clean Technology Trends in 2011 provides key information and detailed insight into clean technology industry trends. It contains a detailed analysis on the major trends in various domains of the clean technology sector. It discusses the emergence of Lithium-ion and Nickel-metal Hydride battery technology in the advanced battery segment. The report analyses the impact of government regulations in the water and wastewater management industry,
GBI: Manufacturing of Biologics on reports-research.com
GBI Research's report, Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies, provides the key data and analyzes the major challenges and drivers for the bio-manufacturing industry. The report also analyzes the strengths, weaknesses of and opportunities for the stakeholders in the manufacturing of biologics. The report also discusses the key market drivers and barriers for the growth of
GBI: Power Management Integrated Circuits (IC) Market to 2020 on reports-researc …
GBI Research’s Semi-conductor’s report, Power Management Integrated Circuits (IC) Market to 2020 - Battery Powered Portable Gadgets to Drive Sales Growth provides the key market statistics and analysis on the Power Management IC industry. The report covers the key market drivers, restraints and growth forecasts for the major segments in the Power Management Industry. Rapid adoption of smart phones is expected to boost the demand of Power Management ICs. The
GBI: Smart Grid Market Analysis and Forecasts to 2020 on reports-research.com
The report provides analysis of the Global Smart Grid Market and Forecasts for the four major geographical regions up to 2020. The research analyzes the state of smart grid deployments in the four major geographical regions and it future potential up to 2020. The research also provides the historical and forecast of revenues for four different smart grid technologies including smart meters, broadband over power line, HVDC and energy storage. Government
GBI: Power Market in Eastern Europe to 2020 on reports-research.com
GBI Research has released its power report Power Market in Eastern Europe to 2020: New Investments to Drive Power Demand in the Region. The report gives an in-depth analysis of the top 10 Eastern Europe power markets, (Russia, Lithuania, Bulgaria, Slovakia, Poland, Hungary, Romania, Croatia, Czech Republic and Ukraine). The research analyzes the regulatory framework and infrastructure of the power sector in these 10 countries. It provides a detailed forecast